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Abstract
Reprogramming of adult differentiated cells to induced pluripotent stem cells (iPS) cells has been achieved by over-
expression of specific transcription factors. Nuclear reprogramming induces a series of profound changes at the telomeres
of the parental differentiated cells, including a telomerase-dependent telomere elongation and the remodeling of telomeric
chromatin. In particular, iPS cells show a decreased density of H4K20me3 heterochromatic mark at telomeres compared to
the parental cells. Suv4-20h1 and Suv4-20h2 histone methytransferases (HMTases) are responsible for the trimethylation of
H4K20 at telomeres, as cells deficient for both HMTases show decreased levels of H4K20me3 at telomeric chromatin. Here,
we set to address the role of the Suv4-20h enzymes in telomere reprogramming by generating bona-fide iPS cells from
mouse embryonic fibroblasts (MEFs) double null for both HMTases (Suv4-20dn MEFs). We found that Suv4-20h deficiency
enhances telomere elongation during reprogramming without altering their ability to protect the chromosome ends or the
efficiency of reprogramming. Moreover, teratomas generated from Suv4-20dn iPS cells also have elongated telomeres and
an increased growth rate when compared to wild-type controls. These results indicate that abrogation of Suv4-20h enzymes
and loss of heterochromatic mark H4K20me3 at telomeric heterochromatin facilitates telomere reprogramming and
provides an increased tumorigenic potential to the resulting iPS cells.
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Introduction
Mouse and human somatic cells can be reprogrammed to the
so-called induced pluripotent stem (iPS) cells by simultaneous over
expression of four or less transcription factors related to stem cell
pluripotency [1,2,3,4,5,6]. These cells have enormous potential for
the generation of patient-specific cells to be used for regenerative
medicine, in vitro modeling of human diseases, and drug discovery.
The molecular mechanisms by which the transcription factors
enable this de-differentiation process are not fully understood, but
in vitro reprogramming involves the acquisition of an embryonic
stem cell gene expression profile and global epigenetic changes
[5,6,7,8]. Thus, epigenetic marks are properly reprogrammed
during iPS cell generation, reaching a pattern that resembles that
of ES cells, with a more open chromatin compared to
differentiated cells [9]. The remodeling of the chromatin to a
more relaxed conformation by the removal of the multilayered
marks of epigenetic silencing, such as histone and DNA
methylation, constitute an essential part of the de-differentiation
process. In accordance, several chromatin-remodeling proteins, as
well as demethylation-promoting agents and histone deacetylase
inhibitors that promote chromatin opening have been shown to
regulate reprogramming [8,10,11,12,13].
Telomeres are reprogrammed during mouse iPS cell generation
to adopt features similar to those characteristic of ES cell telomeres
[14,15]. Telomeres are heterochromatic structures at the end of
chromosomes that protect them from degradation and from being
detected as double-strand DNA breaks [16,17]. Telomeres
comprise complexes of tandem DNA repeats bound by a
specialized multiprotein complex known as shelterin [17].
Mammalian telomere length and integrity play an important role
in processes such cancer and aging, characterized by defects in
telomere length [18]. Thus, telomeres have been shown to shorten
associated to increasing age [19] and contribute to organismal
aging by limiting the proliferative capacity of adult stem cells
[20,21,22]. Telomere length is maintained by telomerase, a
reverse transcriptase enzyme [23] whose expression is restricted
to embryonic development as well as to adult stem cell
compartments [20,21,22,24]. Telomere-elongation is in turn
regulated by the epigenetic status of telomeric chromatin
[25,26]. In particular, telomeric and subtelomeric regions are
enriched in histone marks characteristic of repressed heterochro-
matin domains, such as trimethylation of H3K9 and H4K20 and
binding of heterochromatin protein 1 (HP1) [27,28,29] and
subtelomeric DNA is heavily methylated [29]. Loss of these
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heterochromatic marks is concomitant with excessive telomere
elongation [27,28,29].
During reprogramming, a telomerase-dependent telomere
elongation occurs in iPS cells derived from mouse embryonic
fibroblasts (MEFs), which continue post-reprogramming until
reaching ES cell telomere length [15]. Moreover, generation of
iPS cells involves a change in the epigenetic status of telomeres,
demonstrating that telomeric chromatin is dynamic and repro-
grammable depending of the differentiation stage of cells. In
particular, iPS cells show a decreased density of H4K20me3 at
telomeric repeats [14,15] compared to the parental cells. It is
thought that chromatin remodeling is a requisite for telomerase-
dependent telomere elongation during iPS cell generation.
In has been described that the enzymatic activities responsible
for the trimethylation of H4K20 at telomeres are the Suv4-20h
histone methytransferases [27]. Murine Suv4-20h1 and Suv4-20h2
are involved in di- and trimethylation of H4K20 in heterochro-
matic domains, where they play an important role in chromatin
maintenance [27,30,31]. Cells simultaneously deficient for both
enzymes, Suv4-20 double-null (dn), show a chromatin-wide
transition to H4K20 monomethylation and a marked decrease
in H4K20me3 at pericentric and telomeric chromatin compared
to wild-type controls [27,31,32]. In view of the role of Suv4-20h
enzymes in maintenance of the H4K20me3 heterochromatic mark
on telomeric chromatin and the loss of this mark on telomeres
during iPS cell generation, we asked whether Suv4-20h HMTases
may play a role in regulating telomere reprogramming. Here, we
show that abrogation of Suv4-20h enzymes accelerates telomere
elongation during reprogramming. Also, Suv4-20dn iPS cells-
induced teratomas show an increased growth rate and elongated
telomeres when compared to wild-type controls. Our results
indicate that loss of heterochromatic mark H4K20me3 in
telomeric heterochromatin facilitates telomere reprogramming.
Materials and Methods
Cell culture
Primary MEFs derived from wild type or Suv4-20dn embryos
(C57BL6 genetic background) were a kind gift from Thomas
Jenuwein. MEF were cultured in standard DMEM medium with
10% FBS (Gibco). iPS cells were cultured in DMEM (high glucose)
supplemented with serum replacement (KSR, Invitrogen), LIF
1000 u/ml, non-essential amino acids, glutamax and beta-
mercaptoethanol.
Generation of mouse iPS cells
Reprogramming of primary (passage 2–4) mouse embryo
fibroblasts derived either from wild type or Suv4-20dn embryos
(MEFs, of C57BL6 genetic background) was performed essentially
as previously described by us [15] following modifications of a
previous protocol [33]. Briefly, retroviral supernatants were
produced in HEK-293T cells (ATCCH Number CRL-11268TM)
(56106 cells per 100-mm-diameter dish) transfected with the
ecotropic packaging plasmid pCL-Eco (4 mg) together with either
one of the following retroviral constructs (4 mg), pMXs-Klf4,
pMXs-Sox2 or pMXs-Oct3/4 (obtained from Addgene). Trans-
fections were performed using Fugene-6 transfection reagent
(Roche) according to the manufacturer’s protocol. Two days later,
retroviral supernatants (10 ml) were collected serially during the
subsequent 48 hours, at 12 hour intervals, each time adding fresh
medium to the cells (10 ml). The recipient MEFs had been seeded
the previous day (26105 cells per 60-mm-diameter dish) and
received 1 ml of each of the corresponding retroviral supernatants
(a total of three). This procedure was repeated every 12 hours for 2
days (a total of 4 additions). After infection was completed, media
was replaced with standard ES media supplemented with
knockout serum replacement (KSR, Invitrogen). Cultures were
maintained in the absence of drug selection with daily medium
changes. Reprogramming was assessed 2 weeks post-infection by
counting alkaline phosphatase-positive colonies. Alkaline phos-
phatase staining was performed according to manufacturer’s
instructions (Alkaline Phosphatase Detection kit (Millipore). The
results were normalized to the respective efficiencies of retroviral
transduction as assessed by transducing with the three
pMXsOct3/4, pMXsKlf4, pMXsSox2 retroviruses plus a retrovi-
rus expressing GFP. Colonies were picked after 2 weeks and
expanded on feeder fibroblasts using standard procedures.
iPS-chimeras
The capacity of the wt and Suv4-20dn iPS clones to generate
chimeras in vivo was tested by microinjection into C57BL/6J-
Tyr(C-2J)/J (albino) blastocysts, or by aggregation with CD1
(albino) morulae and assessment of hair color in the resulting
progeny. Mice were treated in accordance with the Spanish Laws
and the Guidelines for Humane Endpoints for Animals Used in
Biomedical Research. The Spanish National Cancer Research
Centre (CNIO) is part of the ‘‘Carlos III’’ Health Institute (ISCIII)
and all protocols were previously subjected and approved by the
Ethical Committee of the ISCIII; approval ID numbers: PA-311,
PA- 352.2 and PA-142/07.
Teratoma formation
Mice (nu/nu) were subcutaneously injected with 16106 cells of
each iPS cell clone. Tumor growth was measured at the indicated
days post-injection with a caliber, and tumor volume was
calculated according to the formula: long diameter6(short
diameter)260.51.
Histopathology and immunohistochemistry
After mice excision, the teratomas were fixed in 10% buffered
formalin (Sigma) and embedded in paraffin. For histopathological
analysis of teratomas, tumours were sectioned and sections were
stained with haematoxylin and eosin according to standard
procedures. For immunohistochemical studies Nanog antibody
(Novus Biologicals, NB100-58842, 1:800) and Oct3/4(H-134)
antibody (Santa Cruz Biotechnology, sc-9081, 1:150) were used
following manufacturer’s instructions. Following incubation with
the primary antibodies, positive cells were visualized using 3,3-
diaminobenzidine tetrahydrochloride plus (DAB+) as a chromo-
gen.
Western blot
Cell extracts were prepared using RIPA buffer, resolved on
NuPAGE 4–12% gradient Bis-Tris gels, transferred to nitrocellu-
lose and hybridized using Abs against Nanog (1:1000; Chemicon
AB 5731), Oct4 (H-134) (1:500; SantaCruz sc-9081) and tubulin
(1:10000 SIGMA T6557).
TRF analysis
Cells were included in agarose plugs, and TRF analysis was
performed as described previously [34].
Chromosomal aberrations
FISH hybridization was performed as described before [29,35].
At least 12 metaphases per genotype were scored for chromosomal
aberrations by superimposing the telomere image on the DAPI
chromosomes image using the TFL-telo software.
Role of Suv420 HMTases in Reprogramming
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e25680
Telomere length analysis using telomere Q-FISH on
metaphases
We prepared metaphases and performed Q-FISH hybridization
as previously described [29,35]. To correct for lamp intensity and
alignment, images from fluorescent beads (Molecular Probes,
Invitrogen) were analyzed in parallel, using the TFL-Telo program
(a gift from P. Lansdorp, Terry Fox Laboratory, British Columbia
Cancer Research Centre, Vancouver, Canada). Telomere fluo-
rescence values were extrapolated from the telomere fluorescence
of lymphoma cell lines LY-R (R cells) and LY-S (S cells) with
known telomere lengths of 80 and 10 kb, respectively. There was a
linear correlation (r2 = 0.999) between the fluorescence intensity of
the R and S telomeres. We captured the images using a CCD
camera (FK7512; COHU) on a fluorescence microscope (DMRB;
Leica). We captured the images using Q-FISH software (Leica) in
a linear acquisition mode to prevent the oversaturation of
fluorescence intensity. TFL-Telo software [36] was used to
quantify the fluorescence intensity of telomeres from at least 5–
10 metaphases for each data point.
Telomere length analysis of teratoma sections
Teratoma sections were deparaffinated and quantitative
telomere fluorescence in situ hibridization (Q_FISH) was perfomed
as described [37].
ChIP assay
ChIP assays were performed as previously described [28]. In
brief, after cross-linking and sonication, chromatin from 46106
cells were used per each immunoprecipitation with protein A/G
Plus agarose beads (Santa Cruz Biotechnology, sc-2003) and the
following antibodies: 6 ug of anti-histone H3 (# ab1791, Abcam),
6 ug of anti-H3K9me3 (#07-442, Upstate Biotechnology), 6 ug of
anti-H4K20me3 (# 07-749, Upstate Biotechnology), 8 ml of rabbit
polyclonal antibody to TRF1, raised in our laboratory against full-
length mouse TRF1 protein, or preimmune serum. The
immunoprecipitated DNA was transferred to a Hybond N+
membrane using a dot blot apparatus. The membrane was then
hybridized with either a telomeric probe containing TTAGGG
repeats or a probe recognizing major satellite sequences, which is
Figure 1. Generation of bona-fide pluripotent mouse Suv4-20dn iPS cells. a. Quantification of relative reprogramming efficiency obtained
with Suv4-20dn MEF compared to that obtained with wild-type MEF. Efficiency of iPS generation was calculated as the number of alkaline
phosphatase- positive colonies and normalized to retroviral infection efficiency as determined by GFP fluorescence (see Methods). Note that the
efficiency of iPS generation is similar in Suv4-20dn MEF compared to the wild-type controls. Indicated statistics was performed using a Student’s t-
test. Error bars indicate the standard error. n, represents number of independent MEF cultures. b. Robust expression of endogenous pluripotency
markers Oct4 and Nanog in wt and Suv4-20dn iPS cells (passage 5) as measured by western-blot. Four individual iPS cell clones per genotype are
shown. Note that wild-type and Suv4-20dn iPS cells express similar levels of endogenous Nanog and Oct4 than ES cells of the same genetic
background (C57BL6), while MEF do not express these factors. c. Representative example of Suv4-20dn iPS cells contribution to mouse chimerism. d.
Representative examples of the teratomas generated with wt and Suv4-20dn iPS cells 24 days after injection. Note that teratomas from both
genotypes show tissues derived from the three germ layers (ectoderm, mesoderm, endoderm). Scale bar, 100 mm.
doi:10.1371/journal.pone.0025680.g001
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characteristic of pericentric heterochromatin. Quantification of
the signal was performed with ImageJ software. The amount of
telomeric and pericentric DNA after ChIP was normalized to the
total telomeric or centromeric DNA signal respectively for each
genotype, as well as to the H3 abundance at these domains, thus
correcting for differences in the number of telomere repeats or in
nucleosome spacing.
Telomere transcription
Telomere transcription was studied as described [38]. Total
RNA was prepared using Trizol (Invitrogen). Northern blotting
was performed as described previously [38]. The 1,6 kb telomere
DNA probe used to detect the telomeric RNA was a kind donation
from Dr. Titia de Lange, Rockefeller University, NY, USA. The
DNA probe was labelled by random priming (Rediprime, GE
healthcare).
Results
Suv4-20dn cells can be efficiently reprogrammed into
bona-fide iPS cells
Wt and Suv4-20dn mouse embryonic fibroblasts (MEFs) were
reprogrammed using retroviral vectors expressing a combination
of three reprogramming factors (Oct4, Klf4 and Sox2) previously
shown by us to reprogram wild-type MEFs into bona fide
pluripotent iPS cells [15]. Reprogramming efficiency was
calculated as the number of iPS cell colonies obtained at day 14
post-infection with the three reprogramming factors relative to the
total number of cells initially infected (infection efficiency was
measured in quadruple infections with the three factors plus GFP,
all at equal proportions, and analyzed by flow cytometry to detect
the proportion of GFP-positive cells). Suv4-20dn MEFs were
reprogrammed with similar efficiency to that of wt MEFs (Fig. 1A),
indicating that loss of H4K20 trimethylation in heterochromatic
regions does not alter the reprogramming capacity of the cells.
The resulting iPS cell colonies we isolated, expanded and tested for
pluripotency by several means. First, both wt and Suv4-20dn iPS
cells showed a robust expression of the pluripotency markers Oct4
and Nanog, as measured by Western-blot (Fig. 1B). Next, we
confirmed their ability to contribute to mouse chimerism when
microinjected into C57BL6-Tyrc (albino) blastocysts or when
aggregated with CD1 (albino) morulae (Fig. 1C and Table S1).
Finally, both wt and Suv4-20dn iPS cells were able to induce
teratomas when injected in immunodeficient mice, with presence
of tissues derived from all the three germ layers (Fig. 1D) and with
similar levels of cell differentiation as measured by Oct4 and
Nanog staining (Fig. S1). Altogether, these results indicate that
MEFs lacking the HMTases Suv4-20h1 and Suv4-20h2 activities
can be efficiently reprogrammed into bona-fide iPS cells.
Reprogramming of telomeric chromatin in Suv4-20dn iPS
cells
Along the reprogramming process the epigenetic signature of
telomeric heterochromatin is changed, and the density of
H4K20me3 heterochromatic mark is decreased compared to
differentiated MEFs. [15]. We previously reported [27] that Suv4-
20dn MEFs show a lower density of H4K20me3 at telomeric
chromatin compared with wild-type MEFs, demonstrating that the
Suv4-20h HMTases are responsible for the establishment of this
mark at telomeres, as well as that Suv4-20dn MEFs telomeric
chromatin is more open than in wt cells. To test whether this
change in chromatin structure affects the efficiency of reprogram-
ming of telomeric chromatin in Suv4-20dn cells, we performed
chromatin immunoprecipitation (ChIP) in wt and Suv4-20dn iPS
cells (three or four independent iPS cells clones per genotype).
Immunoprecipitated DNA was detected by Dot-Blot with a
telomeric probe or a pericentric probe as a control.. As expected,
Suv4-20dn iPS cells showed very low levels of H4K20 trimethyla-
tion at the telomeric and pericentric chromatin (Fig. 2 A–B) when
compared to wt iPS.We show that Suv4-20dn iPS cells present
similar density of H3K9me3 mark and TRF1 protein at telomeres
(Fig. 2A), confirming a proper reprogramming of heterochromatin
at telomeres in these cells.
Telomeres elongate to a greater extent in Suv4-20dn iPS
cells
As part of the reprogramming process, telomeres elongate, and
thus ‘‘rejuvenate’’, in a telomerase-dependent manner, to finally
reach hyper-long telomeres characteristic of ES cells [15]. It is
thought that the remodeling of telomeric chromatin during
Figure 2. Reprogramming of telomeric chromatin in Suv4-20dn
iPS cells. a–b. ChIP of wt and Suv4-20dn iPS cells (passage 9) with the
indicated antibodies. Quantification of immunoprecipitated telomeric
(a) and pericentric (b) repeats was normalized to input signals. ChIP
values are represented as percentages of the wild-type, which was set
to 1. Note that H4K20me3 mark is drastically reduced in Suv4-20dn iPS
cells when compared to wt iPS cells, while H3K9me3 and TRF1 levels at
telomeres are similar in both genotypes. n represents number of
independent iPS cells clones. Indicated statistics was performed using a
Student’s t-test. Error bars correspond to standard error.
doi:10.1371/journal.pone.0025680.g002
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reprogramming [15] could be required to allow telomerase access
to the telomere and posterior telomere lengthening. Since
telomeric chromatin in Suv4-20dn MEFs presents a lower density
of the repressive H4K20me3 heterochromatic mark and a more
open structure than that of wt cells, we set to determine whether
this epigenetic difference could affect the efficiency of telomere
elongation during reprogramming. To this aim, we measured
telomere length of wt and Suv4-20dn iPS cells (four independent
iPS cells clones per genotype, passage 5) and compared them with
that of their corresponding parental MEFs. First, we measured the
length of TTAGGG repeats using Southern blot terminal
restriction fragment (TRF) analysis. In agreement with previous
findings [27], abrogation of the repressive H4K20me3 chromatin
mark at telomeres led to initially slightly longer telomeres in
parental Suv4-20dn MEFs compared to wt MEFs (Fig. 3A). As
expected, nuclear reprogramming resulted in net telomere
elongation both in wt and Suv4-20dn iPS cells compared to their
corresponding parental MEFs (Fig. 3A), indicating that the
H4K20me3 mark is not required for efficient telomere elongation
by telomerase. Interestingly, the relative increase in telomere
length associated to nuclear reprogramming was greater in Suv4-
20dn iPS cell clones compared to wt iPS clones, both at passage 5
post clone isolation, suggesting a more proficient telomere
elongation in these cells. To confirm these data, we performed a
quantitative FISH (Q-FISH) on metaphases using a telomere-
specific probe. The results confirmed that initial average telomere
length in Suv4-20dn MEFs (40.3 Kb) was higher than in wt MEFs
(33.0 Kb) (Fig. 3B and Fig. S2) and that both wt (46.5 Kb) and
Suv4-20dn (61.8 Kb) iPS cells at passage 5 show longer telomeres
than their corresponding parental MEF (Fig. 3B and Fig. S2).
Interestingly, when net telomere elongation in iPS cells was
calculated (Fig. 3C), we observed a significantly higher increase in
telomere length in Suv4-20dn iPS cells (20.8 Kb) than in wt iPS
cells (13.5 Kb) when compared to their parental MEFs. These
results indicate that telomeres elongate to a greater extent during
reprogramming of Suv4-20dn cells when compared to wt controls.
Suv4-20dn iPS cells produce more TERRA
Telomeres are actively transcribed in mammalian cells
generating long, non-coding RNAs known as TelRNAs or
TERRAs [38,39], that are bound by RNA-binding proteins
[40,41]. They remain associated to the telomeric chromatin,
Figure 3. Enhanced telomere elongation in Suv4-20dn iPS cells. a. TRF results obtained with MEF (passage 3) derived from two embryos of
each of the wild-type and Suv4-20dn genotypes and two independent iPS cells clones (passage 5) obtained from each MEF (a total of four
independent iPS cells clones per genotype). Note the longer telomeres in Suv4-20dn MEF compared to wt MEF. Also note the telomere elongation in
wt iPS cells when compared to the parental MEF, which is exacerbated in Suv4-20dn iPS cells. A white line is shown to facilitate the comparison of TRF
sizes between different samples. b. Quantification of average telomere length (kilobases) as determined by Q-FISH on metaphases. n indicates
number of independent MEF cultures or iPS cells colonies. Error bars correspond to standard error. Indicated statistics were performed using a
Student’s t-test. c. Average telomere lengthening (kilobases) in wt and Suv4-20dn iPS cells independent clones (passage 5) compared to their
corresponding parental MEF (passage 3), as determined by Q-FISH on metaphases. Note the higher net telomere elongation in Suv4-20dn iPS cells,
indicating an enhanced telomere lengthening in these cells. n indicates number of independent MEF cultures or iPS cells colonies. Error bars
correspond to standard error. Indicated statistics were performed using a Student’s t-test.
doi:10.1371/journal.pone.0025680.g003
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where they have been proposed to act as negative regulators of
telomere length [38]. TERRA levels are positively correlated with
telomere length [38], suggesting that individual telomeres can
produce different amounts of transcripts according to their length.
We have previously described that, in agreement with their longer
telomeres, TERRA levels are efficiently increased in iPS compared
to the MEFs [15].
To assess the impact of loss of the H4K20m3 heterochromatic
mark on TERRA expression on reprogrammed cells, we measured
TERRA levels by northern blot analysis in wt and Suv4-20dn iPS cells
(four independent iPS cells clones per genotype) and their
corresponding parental MEFs. As previously described [38], and in
agreement with their more relaxed telomeric chromatin, Suv4-20dn
MEFs showed higher levels of TERRA than wt MEFs (Fig. 4 A and
B). Interestingly, the fold increase in TERRA levels in Suv4-20dn iPS
cells when compared to their parental MEFs (4 fold increase), was
higher than in the case of wt cells (2.8 fold increase) (Fig. 4 A and B), in
accordance to their enhanced telomere lengthening during repro-
gramming (Fig. 3 C). These results also support the notion that
abundance of TelRNAs is positively correlated with telomere length.
Chromosomal aberrations in Suv4-20dn iPS cells
We previously showed that decreased abundance of H4K20me3
at the telomeres of Suv4-20dn MEFs does not lead to increased
chromosomal aberrations involving telomeric repeats [27],
suggesting that longer telomeres in Suv4-20dn cells remain fully
capped. However, Suv4-20dn MEFs are more prone to chromo-
somal breaks and gaps as the result ionizing irradiation, suggesting
an increased sensitivity of these cells to DNA damage [32]. Here,
we set to address whether Suv4-20dn iPS cells were genetically
stable or instead showed increased chromosomal aberrations. To
assess this question, we performed fluorescent in situ hybridization
(FISH) staining in metaphases using a telomeric probe, and
analyze for the presence of chromosomal and telomeric aberra-
tions. As shown in Fig. 5 A, Suv4-20dn iPS cells show an increased
frequency of chromosomal fragments and breaks when compared
to their parental differentiated MEFs, suggesting that reprogram-
ming of the chromatin in cells lacking the H4K20me3 mark
generates a conformation more fragile and prone to chromosomal
breakage. In contrast, Suv4-20dn iPS cells show similarly low
frequency of end-to-end fusion events (Fig. 5 B) and multitelomeric
signals (Fig. 5 C) than wt iPS cells, indicating that reprogramming
of telomeric chromatin in the absence of H4K20me3 mark does
not alter the ability to protect the chromosome ends. Interestingly,
our results show that both wt and Suv4-20dn iPS cells exhibit a
significantly lower frequency of multitelomeric signals (MTSs) than
their corresponding parental MEF, suggesting the existence of a
selective mechanism that prevents the reprogramming of cells that
carry this kind of telomere aberration, that results from increased
telomere fragility and is increased under conditions of replication
stress [37,42,43,44]. It has been described that tumor suppressor
p53 is critical in preventing the generation of human and mouse
pluripotent cells from suboptimal parental cells carrying DNA
damage, such as critically short telomeres or exogenously inflicted
damage [45]. We asked whether p53 would also be involved in the
inhibition of reprogramming of cells presenting MTSs. To address
this question, we measured the frequency of MTSs in wt and
p532/2 iPS cells and compared them with their corresponding
parental MEF. As shown in Fig. 5 D, p532/2 iPS cells show
frequencies of MTSs similar to their parental MEF, indicating a
role of p53 in preventing reprogramming of cells with fragile
telomeres.
Figure 4. Increased levels of TERRA in Suv4-20dn iPS cells. a.
Expression of TERRA in the indicated cells types as measured by
Northern blot hybridization with a telomeric probe. A probe for the 18S
ribosomal subunit was used as a loading control. b. Quantification of
TERRA levels by Northern-blot shown in a. TERRA values were
normalized against the signal for the 18S subunit to correct for
differences in loading. Fold changes of iPS cells (passage 5) clones
TERRA expression relative to their parental MEF (passage 3) are
indicated. Note the higher increase in TERRA expression in Suv4-20dn
iPS cells. n indicates number of independent MEF cultures or iPS cells
colonies. Mean and standard error are shown.
doi:10.1371/journal.pone.0025680.g004
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Teratomas derived from Suv4-20dn iPS cells grow faster
and have longer telomeres
The generation of tumor cells involves a series of epigenetic
changes, such as global decrease in DNA methylation, H4K20
trimethylation and H4K16 acetylation [46]. Progressive loss of
H4K20me3 and decreased levels of Suv4-20h2 have been
associated with several cancers [47,48,49,50], suggesting that
abnormal regulation of H4K20me3 could be an important factor
in oncogenesis or cancer progression. To further address the role
of H4K20me3 and Suv4-20h enzymes in oncogenesis, we
characterized the teratomas derived from injection of wt and
Suv4-20dn iPS cells into immunodeficient mice. First, we calculated
the growth rate of the teratomas by measuring their volume along
several days after injection. As shown in Fig. 6 A, teratomas
derived from injection of Suv4-20dn iPS cells grow significantly
faster than those derived from wt iPS cells, indicating that loss of
Suv4-20 enzymes and H4K20me3 mark provides a growth
advantage to the tumor cells. We next addressed whether the
differences in telomere length observed between the wt and Suv4-
20dn iPS cells were reflected in the corresponding teratomas. To
this aim, we performed telomere quantitative FISH (Q-FISH)
analysis on teratoma sections. The results indicate (Fig. 6 B) that
average telomere length in Suv4-20dn teratomas is higher than in
the wt controls. The presence of longer telomeres associated with a
faster teratoma growth rate supports a model were loss of
H4K20me3 mark in Suv4-20dn cells favors an enhanced elongation
of telomeres during reprogramming, which, in turn, may confer a
growth advantage and increased tumorigenesis potential to the
tumor cells
Discussion
Current evidence suggests that chromatin remodeling proteins
and reagents that induce a less compacted chromatin conforma-
tion also facilitate the reprogramming process [8,10,11,12,13], in
Figure 5. Abrogation of Suv4-20h enzymes does not increase telomeric aberrations in Suv4-20dn iPS cells. Frequency of (a)
chromosomal breaks and fragments, (b) end-to-end fusions and (c) multitelomeric signals, in wt and Suv4-20dn MEF (passage 3) and iPS cells (passage
5). (d) Frequency of multitelomeric signals in wt and p532/2 MEF (passage 3) and iPS cells (passage 5). The number of metaphases analyzed in each
case is indicated. Mean and standard error are shown. Indicated statistics were performed using a Student’s t-test.
doi:10.1371/journal.pone.0025680.g005
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accordance with the notion that elimination of silencing epigenetic
marks is a key step in the generation of iPS cells. We previously
showed that abrogation of Suv4-20h enzymes results in global loss
of H4K20 di- and trimethylation heterochromatic marks and a
global change to H4K20 monomethylation [27,31,32]. Here, we
set to address the impact of this profound epigenetic change in
nuclear reprogramming by generating Suv4-20dn iPS cells.
Interestingly, we did not observe higher reprogramming efficien-
cies in Suv4-20dn cells compared to wild-type cells. This is most
likely due to the fact that Suv4-20dn MEFs show severe
proliferation defects and enter crisis earlier than wt cells [32].
Since reprogramming requires multiple cell division to silence
lineage-specific genes and activate embryonic markers [51], the
proliferative defect in Suv4-20dn MEFs could reduce their
reprogramming capacity. Thus, it is plausible that only a subset
of the infected cells would be able to complete the number of cell
divisions required to fulfill the reprogramming process, thus
masking a possible reprogramming advantage conferred by the
presence of an open chromatin in these cells. In any case, we show
here that reprogramming of Suv4-20dn cells generates bona fide iPS
cells that express stemness markers, contribute to mouse
chimerism and induce teratomas that differentiate in tissues
derived from the three germ layers.
Nuclear reprogramming induces a series of profound changes at
the telomeres of parental differentiated cells, leading to ‘‘rejuve-
nated’’ telomeres more similar to those of ES cells. In particular,
during iPS cell generation, and as part of a genome-wide opening
of the chromatin in this process, heterochromatic mark
H4K20me3 is drastically reduced at telomeric chromatin. In
addition, telomerase expression is activated and a continuous
telomerase-dependent telomere elongation occurs, until reaching
ES cell telomere length [14,15]. A current model proposes that
remodeling of telomeric chromatin may be required to allow
telomerase access to the end of the telomere and posterior
telomere lengthening. In line with this, we observe here that the
loss of H4K20me3 in Suv4-20dn MEFs correlates with an
enhanced telomere elongation during reprogramming of these
cells, suggesting that the ‘‘relaxed’’ chromatin could facilitate the
access of telomerase to the telomere during iPS cell generation.
These data support the idea that chromatin remodeling at
telomeres is a prerequisite for telomerase-dependent telomere
elongation during reprogramming.
Telomeres function to guard chromosomes against degradation,
fusions, and rearrangements [16]. Telomere capping depends on
telomere length, telomeric chromatin structure and the shelterin
complex [25,52]. Loss of this telomere protection function results
in chromosomal instability, including end-to-end fusions and
occurrence of multitelomeric signals [52]. The results described
here show that Suv4-20dn iPS cells present similarly low frequency
of end-to-end fusion events and multitelomeric signals than wt iPS
cells, indicating that they maintain their protective telomere
function in the absence of the H4K20me3 mark. Multitelomeric
signals are aberrant structures whose frequency increases under
conditions of replication stress, such as aphidicolin treatment [43].
As telomeres resemble fragile sites [44], increased frequencies of
MTS are a direct indicator of telomere fragility resulting from
replication fork stalling [43,44]. In this study, we observed that the
frequency of MTS was greatly reduced in iPS cells compared to
MEF, indicating that reprogramming of cells suffering of
replicative stress is abolished. Interestingly, we show here that
tumor suppressor p53, which is critical in aborting the repro-
gramming of cells carrying DNA damage, such as critically short
Figure 6. Suv4-20dn iPS cells-induced teratomas grow faster than the wt and have longer telomeres. a. Teratoma growth in mice (nu/nu)
subcutaneously injected with 16106 cells of each wt and Suv4-20dn iPS cells. Teratoma growth rate was calculated by measuring their volume along
several days after iPS cell injection and expressed as net volume increased relative to the first measurement. iPS cells were injected at passage 5. Note
that teratomas derived from Suv4-20dn iPS cells present a higher growth rate that those derived from wt iPS cells. n indicates number of teratomas
measured from each genotype. Mean and standard error are shown. Indicated statistics were performed using a Student’s t-test. b. Quantification of
average telomere length (a.u.) as determined by Q-FISH on wt and Suv4-20dn teratoma sections. Note the longer telomere length in Suv4-20dn
teratomas compared with wt controls. n indicates number of telomeres analyzed for each genotype. Error bars correspond to standard error.
Indicated statistics were performed using a Student’s t-test.
doi:10.1371/journal.pone.0025680.g006
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telomeres or exogenously inflicted DNA damage [45], is also
involved in preventing the reprogramming of cells that present
higher loads of MTS, confirming a general role of p53 as a
‘‘reprogramming barrier’’ that prevents the generation of iPS cells
from sub-optimal parental cells. It has been described that the
DNA damage response kinase ATR, which functions to protect
and stabilize stalled replication forks at common genomic fragile
sites, has an important role in suppressing telomere fragility and
occurrence of MTS [43,53]. Thus, a possibility exists that, during
reprogramming, the presence of MTS in parental cells could lead
to activation of ATR kinase, ultimately resulting in a p53-
mediated apoptosis process that would eliminate these cells to
prevent the generation of genetically unstable iPS cells, although
data supporting this hypothesis is not available.
Interestingly, p53 is critical to control the spreading of damaged
cells in both reprogramming and malignant transformation,
suggesting the existence of common mechanisms between
reprogramming and cancer development. There are other
common features shared between iPS reprogramming and
tumorigenesis. Thus, in both cases the normal differentiation
processes are altered, global epigenetic changes are necessary and
the activity of transcriptional regulators is required to generate a
new gene expression program according to the change in cell fate
[54]. Also, reprogrammed cells and cancer cells activate
telomerase expression [55,56,57,58]. Moreover, as mentioned,
these multistep processes have to overcome the common safety
mechanism of ‘‘quality control’’ exerted by p53, designed to avoid
the processes and maintain the cell identity, and thus, abrogation
of p53 favors the occurrence of reprogramming and tumor
initiation [45,59,60,61,62,63]. Thus, a possibility exists that tumor
initiation would start by de-differentiation of specialized cells that
lose p53 activity and are more prone to reprogram, and that
reprogramming would play a role in the development of cancer. In
this regard, research in the field of reprogramming is opening new
roads in the study of the molecular mechanisms of tumor
initiation.
In line with this, here we show that abrogation of Suv4-20h
enzymes enhances telomere elongation during reprogramming
and generates iPS cells with a faster teratoma growth rate,
indicating that loss of H4K20me3 mark provides a growth
advantage and increased tumorigenesis potential to the tumor
cells. These results are in agreement with the fact that a strong
reduction of H4K20me3 and decreased levels of Suv4-20h2 have
been associated with several cancers [47,48,49,50], which suggests
a possible role of Suv4-20h enzymes as tumor supressors. These
data suggest that abnormal regulation of H4K20me3 confers a
higher tumorigenic potential to both reprogrammed and trans-
formed cells and that Suv4-20h enzymes could play an important
role in oncogenesis or cancer progression. Due to the emerging
connections between the processes of oncogenesis and de-
differentiation, a deeper knowledge of the molecular mechanisms
of reprogramming may open new roads to the identification of
new genes involved in cancer initiation.
Supporting Information
Figure S1 Differentiation of wt and Suv4-20dn terato-
mas. a. Percentage of teratoma area negative for Oct4 (left) and
Nanog (right) staining in teratomas of the indicated genotypes.
Note that wt and Suv4-20dn teratomas show very similar levels of
the pluripotency markers, indicating comparable levels of cell
differentiation. n indicates number of teratomas analyzed for each
genotype. Error bars correspond to standard error. Indicated
statistics were performed using a Student’s t-test. iPS cells were
injected at passage 5. b. Representative images of Oct4 and
Nanog staining in wt and Suv4-20dn teratomas. Scale bar, 200 mm.
(TIF)
Figure S2 Telomere length distributions ofwt and Suv4-
20dn MEF and iPS cells. Quantification and distribution of
telomere length (kilobases) of wt and Suv4-20dn MEF (passage 3)
and iPS cells clones (passage 5) as determined by Q-FISH on
metaphases. Red arrows indicate the iPS cells clones derived from
each parental MEF.
(TIF)
Table S1 Generation of chimeras from wt and Suv4-
20dn iPS cells clones. All the iPS cells used for microinjection
in B6-tyrC-2J blastocysts or aggregation in CD1 morulae
expressed Nanog and Oct-4 (see Fig. 1).
(TIF)
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